The Effects of Lemon Essential Oil Inhalation on Attention in Children With Attention Deficit Hyperactivity Disorder (ADHD)

Lemon Essential Oil Inhalation Improves Sustained Attention in Children With Attention-Deficit/Hyperactivity Disorder: A Placebo-Controlled Trial

This randomized, placebo-controlled clinical trial aims to evaluate the acute effects of lemon essential oil inhalation on sustained attention and visual memory in children diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD). Fifty-two medication-naive children aged 9-16 were randomized to receive either lemon oil or placebo inhalation before cognitive assessments. Primary outcome was sustained attention performance. The study found significant improvements in attention scores in the lemon oil group.

Study Overview

Detailed Description

This randomized, placebo-controlled, single-blind clinical trial investigates the acute effects of lemon essential oil (LEO) inhalation on sustained attention and visual memory in children with attention-deficit/hyperactivity disorder (ADHD). Essential oils, particularly those rich in monoterpenes such as limonene, have demonstrated neuroactive properties through cholinergic modulation and limbic-prefrontal engagement via the olfactory pathway.

Fifty-two children aged 9-16 years, newly diagnosed with ADHD and not receiving any pharmacological treatment, were randomized to either the LEO group or the placebo group. Participants in the LEO group inhaled 5 drops of 100% pure Citrus limon essential oil via a cotton pad for five minutes prior to cognitive testing. The placebo group received an identical application with odorless distilled water.

Cognitive performance was assessed at baseline and 30 days later using the D2 Attention Test (primary outcome) and the Benton Visual Memory Test (secondary outcome). The entire intervention was conducted under standardized conditions, with blinded outcome assessment and strict adherence to procedural fidelity.

This study is the first to evaluate the short-term cognitive effects of lemon essential oil inhalation in children with clinical ADHD and aims to provide evidence for potential non-pharmacological support strategies.

Study Type

Interventional

Enrollment (Actual)

52

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey (Türkiye)
        • Basaksehir Cam ve Sakura City Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Children aged 9 to 16 years
  • Diagnosis of Attention Deficit Hyperactivity Disorder (ADHD) based on DSM-5 criteria
  • Medication-naive (not currently using or previously treated with pharmacological agents for ADHD)
  • No chronic medical or psychiatric comorbidities
  • Capable of completing standardized cognitive assessments (e.g., D2 Attention Test, Benton Visual Memory Test)
  • Written informed consent obtained from a parent or legal guardian
  • Written assent obtained from the child

Exclusion Criteria:

  • Lack of written parental consent or child assent
  • Inability to comply with the study protocol (e.g., refusal to complete cognitive testing or intervention procedure)
  • Current or prior use of ADHD medication
  • Presence of moderate-to-severe ADHD symptoms requiring immediate pharmacological treatment (based on AACAP 2020 and NICE 2019 guidelines)
  • Presence of any chronic medical or psychiatric comorbid condition
  • Diagnosis not confirmed by a board-certified child and adolescent psychiatrist

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Lemon Essential Oil Inhalation (LEO)
Participants in this arm received a single-session inhalation of 100% pure lemon essential oil (Citrus limon) via a sterile cotton pad. Five drops of essential oil were applied to the pad, which was held approximately 5 cm from the participant's nose. The child inhaled the scent for 5 minutes under supervision in a clinical setting. Neuropsychological testing (D2 Attention Test and Benton Visual Memory Test) followed immediately after inhalation.
This intervention consists of a single-session, short-term olfactory exposure to 100% pure lemon essential oil (Citrus limon, ISO 9235 compliant, GC-MS confirmed composition: limonene 67.2%, β-pinene 12.3%, γ-terpinene 9.8%). Five drops were applied to a sterile cotton pad and held approximately 5 cm from the participant's nose. Participants inhaled the aroma for 5 minutes under direct supervision in a quiet, odor-free clinical setting. This intervention was administered immediately prior to standardized neuropsychological assessments measuring attention and visual memory. No ingestion or topical application occurred.
Other Names:
  • Citrus limon aroma
  • LEO
Placebo Comparator: Placebo Inhalation (Distilled Water)
Participants in this arm received a single-session inhalation of distilled water as placebo. Five drops of distilled water were applied to a sterile cotton pad, which was held approximately 5 cm from the participant's nose. The child inhaled the scentless solution for 5 minutes under supervision. Neuropsychological testing (D2 Attention Test and Benton Visual Memory Test) followed immediately after inhalation.
The placebo condition involved the same protocol as the intervention group, using five drops of distilled water applied to a sterile cotton pad. The pad was held approximately 5 cm from the participant's nose, and inhalation lasted for 5 minutes. The procedure was designed to mimic the intervention without olfactory stimulation, ensuring consistency in timing, setting, and administration method.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in D2 Attention Test Total Performance Score (TN-E)
Time Frame: Baseline and Day 30 (after intervention)
The D2 Attention Test evaluates sustained attention and concentration performance. The TN-E (Total Number of Correct Items minus Errors) score reflects attentional capacity. A higher post-intervention TN-E score indicates improved attention. The difference between baseline and Day 30 scores will be compared between the lemon essential oil group and placebo group.
Baseline and Day 30 (after intervention)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Benton Visual Retention Test (BVRT) Score
Time Frame: Baseline and Day 30 (after intervention)
The Benton Visual Retention Test assesses visual memory and visuospatial construction skills. Scores range based on correct reproductions of geometric figures. The change in BVRT scores from baseline to Day 30 will be analyzed to assess the impact of lemon essential oil inhalation versus placebo.
Baseline and Day 30 (after intervention)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 15, 2022

Primary Completion (Actual)

September 30, 2023

Study Completion (Actual)

September 30, 2023

Study Registration Dates

First Submitted

December 24, 2025

First Submitted That Met QC Criteria

May 8, 2026

First Posted (Actual)

May 14, 2026

Study Record Updates

Last Update Posted (Actual)

May 14, 2026

Last Update Submitted That Met QC Criteria

May 8, 2026

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data (IPD) will not be shared for this study due to ethical considerations, privacy protection regulations involving minors, and the absence of prior consent for data sharing beyond the scope of this trial. Additionally, the study was conducted with a small sample size from a single center, limiting the generalizability and reuse of anonymized data for broader analysis.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Attention Deficit Disorder With Hyperactivity (ADHD)

Clinical Trials on Lemon Essential Oil Inhalation

Subscribe